Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.
Tung PH, Chiu TH, Huang AC, Ju JS, Huang CH, Wang CC, Ko HW, Chung FT, Hsu PC, Fang YF, Guo YK, Kuo CS, Yang CT.
Tung PH, et al. Among authors: ju js.
Ther Adv Med Oncol. 2024 Jan 19;16:17588359231222604. doi: 10.1177/17588359231222604. eCollection 2024.
Ther Adv Med Oncol. 2024.
PMID: 38249338
Free PMC article.